The management of Telluride, an international diversified conglomerate based in the United States, believes that the recent strong performance of its wholly owned medical supply subsidiary, Sundanci, has gone unnoticed. To realize Sundanci's full value, Telluride has announced that it will divest Sundanci in a tax-free spin-off. Sue Carroll, CFA, is director of research at Kesson and Associates. In developing an investment recommendation for Sundanci, Carroll has gathered the financial information (in $ million) shown in the tables below: Income Statement 2007 2008 Revenue 598 Depreciation Other operating costs Income before taxes Taxes Net income 474 20 368 86 26 60 23 460 115 35 80 2007 2008 201 326 Balance Sheet Current assets (includes $5 cash in 2007 and 2008) Net property, plant, and equipment Total assets Current liabilities (all non-debt) Long-term debt Total liabilities Shareholders equity Total liabilities and equity 474 675 57 0 57 618 675 489 815 141 0 141 674 815 a) The investment in working capital in 2008 is $ million (Note: a positive (negative) number for outflow (inflow) of cash). b) The investment in long-term fixed capital in 2008 is $ million (Note: a positive (negative) number for outflow (inflow) of cash). C) The free cash flow to firm (FCFF) in 2008 is $ million